PAP
AYTU icon

Persistent Asset Partners’s AYTU BioPharma AYTU Stock Holding History

Persistent Asset Partners’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.7K Sell
37,984
-54,913
-59% -$130K 0.02% 331
2026
Q1 		$254K Buy
92,897
+13,482
+17% +$34.5K 0.09% 169
2025
Q4 		$206K Buy
79,415
+16,963
+27% +$38K 0.09% 210
2025
Q3 		$117K Buy
+62,452
New +$144K 0.08% 153

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Persistent Asset Partners's AYTU Position: Q2 2026 in Review

Persistent Asset Partners reduced its AYTU BioPharma (AYTU) stake by 59% in Q2 2026, selling an estimated $130K and leaving 37,984 shares worth $81.7K. The position accounts for 0.02% of the portfolio, ranked #331.

Persistent Asset Partners first reported a position in AYTU in Q3 2025 and has held it in 4 quarters since. The position peaked at $254K in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • Persistent Asset Partners held 37,984 shares of AYTU BioPharma worth $81.7K as of Q2 2026.
  • Persistent Asset Partners sold 54,913 AYTU BioPharma shares in Q2 2026, an estimated $130K.
  • AYTU BioPharma made up 0.02% of Persistent Asset Partners's portfolio in Q2 2026, its #331 holding.
  • Persistent Asset Partners first reported a position in AYTU BioPharma in Q3 2025 and has held it in 4 quarters since.
  • Persistent Asset Partners's AYTU BioPharma position peaked at $254K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.